Hemostatic Management in Pediatric Patients With Type I von Willebrand Disease Undergoing Oral Surgery: Case Report and Literature Review

被引:4
|
作者
Bornert, Fabien [1 ]
Clauss, Francois [2 ]
Gros, Catherine-Isabelle [1 ]
Faradji, Albert [3 ]
Schmittbuhl, Matthieu [4 ]
Maniere, Marie-Cecile [2 ,5 ]
Feki, Ahmed [1 ]
机构
[1] Univ Hosp, Fac Dent, Dept Oral Med & Oral Surg, F-67000 Strasbourg, France
[2] Univ Hosp, Fac Dent, Dept Pediat Dent, F-67000 Strasbourg, France
[3] Univ Hosp, Fac Dent, Dept Hematol, Reg Ctr Treatment Inherited Bleeding Disorders, F-67000 Strasbourg, France
[4] Univ Hosp, Fac Dent, Dept Dentomaxillofacial Radiol, F-67000 Strasbourg, France
[5] Univ Hosp, Fac Dent, Reference Ctr Oral Manifestat Rare Dis, F-67000 Strasbourg, France
关键词
FACTOR-VIII; CLASSIFICATION; PATHOPHYSIOLOGY; DESMOPRESSIN; EXTRACTIONS; DIAGNOSIS; THERAPY; ANTIGEN; VWD;
D O I
10.1016/j.joms.2011.03.073
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Von Willebrand disease (vWD) (Online Mendelian Inheritance in Man 193400) is a hematologic condition characterized by reduced platelet adhesiveness linked to factor VIII (FVIII) and von Willebrand factor (vWF) deficiencies.(1,2) vWF, otherwise known as factor VIII-related protein is a large glycoprotein synthesized by endothelial cells and megakaryocytes, and represents the major component of the FVIII-vWF multimeric complex. 3 vWF has bridging molecular functions between vessel walls and platelets. vWF level can be measured by immunoassay as plasmatic levels of vWF antigen (vWF: Ag).(4,5) A clinical classification of the different vWD subtypes has been developed according to the levels and patterns of the vWF antigen multimers.(6) Type I vWD represents 50% to 75% of cases and is characterized by quantitative reduction of all multimers, divided into autosomal dominant and recessive forms, with the protein complex FVIII/vWF appearing qualitatively normal.(7) An important clinical variability in the vWD type is observed, with the vWF plasmatic half-time modulating the vWD phenotype, and mild, moderate or severe type I vWD has been described.(8) The most severe reduction is observed in homozygous patients. Type II vWD is divided into IIA, IIB, IIC, IIM, and IIN forms and is characterized by qualitative defects of FVIII/vWF complex.(1) Many allelic variants of subtypes IIA, IIB, and III have been described, showing the genetic heterogeneity of the condition.(1) Type III vWD represents the most severe and rare form of the disease with very low or undetectable levels of vWF.(9) The genetic mutations involved in type 3 vWD exhibit high variability and consist mainly of large partial vWF gene deletions, with insertions resulting in frame shift mutations and splice site mutations.(10) vWD corresponds to the hemorrhagic risk during oral surgery and requires hematologic conditioning in the context of a multidisciplinary team that must include the pediatrician, pediatric dentist, radiologist, hematologist, anesthesiologist, and oral maxillofacial surgeon.(11) However, few cases of pediatric oral surgery in a vWD context have been reported.(12) In the present report, we describe the case of a young girl with vWD type I and 2 impacted anistrophic cone-shaped mesiodens in the premaxilla. Completed by a review of the published data, the aims of the present clinical report are to highlight the importance of the multidisciplinary management consisting of careful hematologic conditioning, atraumatic surgical treatment, and clinical follow-up.
引用
收藏
页码:2086 / 2091
页数:6
相关论文
共 50 条
  • [1] Review of von Willebrand Disease and Acquired von Willebrand Syndrome for Patients Undergoing Cardiac Surgery
    Berger, Jay
    Schwartz, Joseph
    Ramachandran, Sujatha
    Leff, Jonathan D.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2019, 33 (12) : 3446 - 3457
  • [2] Perioperative management of a pediatric patient with suspected type 1 von Willebrand disease undergoing tonsillectomy: a case report
    Oshika, Hiroyuki
    Koyama, Yukihide
    Tsuzaki, Koichi
    Ida, Kohmei
    Andoh, Tomio
    JA CLINICAL REPORTS, 2019, 5 (01)
  • [3] Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review
    Giuffrida, Anna C.
    Siboni, Simona M.
    Baronciani, Luciano
    Poli, Giovanni
    Gandini, Giorgio
    Peyvandi, Flora
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2025, 51 (01) : 73 - 80
  • [4] Perioperative management of a pediatric patient with suspected type 1 von Willebrand disease undergoing tonsillectomy: a case report
    Hiroyuki Oshika
    Yukihide Koyama
    Koichi Tsuzaki
    Kohmei Ida
    Tomio Andoh
    JA Clinical Reports, 5
  • [5] Management of pregnancy in type 2B von Willebrand disease: case report and literature review
    Biguzzi, E.
    Siboni, S. M.
    Ossola, M. W.
    Zaina, B.
    Migliorini, A. C.
    Peyvandi, F.
    HAEMOPHILIA, 2015, 21 (01) : E98 - E103
  • [6] Orthognathic Surgery in Patients With Von Willebrand's Disease: A Report of Four Cases and Literature Review
    Sato, Marika
    Hamada, Hayato
    Hasegawa, On
    Kawase-Koga, Yoko
    Chikazu, Daichi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [7] Maxillary pseudotumor as initial manifestation of von Willebrand disease, type 2: report of a rare case and literature review
    Argyris, Prokopios P.
    Anim, Samuel O.
    Koutlas, Ioannis G.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 121 (02): : E27 - E31
  • [8] Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery
    Windyga, Jerzy
    von Depka-Prondzinski, Mario
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (06) : 1072 - 1079
  • [9] Type 3 von Willebrand Disease in Pregnancy: A Systematic Literature Review
    Makhamreh, Mona M.
    Kass, Stephanie L.
    Russo, Melissa L.
    Ahmadzia, Homa
    Al-Kouatly, Huda B.
    AMERICAN JOURNAL OF PERINATOLOGY, 2021, 38 (05) : 436 - 448
  • [10] Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
    Castaman, Giancarlo
    Linari, Silvia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1029 - 1037